Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.


Turk H., Aliyev A., Celik R., Seker M. , Coban E., Demir T., et al.

Current problems in cancer, ss.100497, 2019 (SCI İndekslerine Giren Dergi) identifier identifier identifier